Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Patent
1993-02-04
1995-10-31
Lacey, David L.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
424534, 424577, 435 2, 604 4, A61K 3514, A61K 3526
Patent
active
054627338
ABSTRACT:
Methods and pharmaceutical compositions for modifying the immune response of a mammal are provided. The pharmaceutical compositions include a pharmaceutically acceptable carrier and a plurality of cells containing psoralen-DNA monoadducts and substantially no psoralen-DNA crosslinks. The preparation is formed by irradiating a suspension of cells with visible light radiation in the presence of psoralen.
REFERENCES:
patent: 4684521 (1987-08-01), Edelson
patent: 4838852 (1989-06-01), Edelson et al.
patent: 5114721 (1992-05-01), Cohen et al.
patent: 5116864 (1992-05-01), March et al.
patent: 5147289 (1992-09-01), Edelson
patent: 5256648 (1993-10-01), Gasparro et al.
Edelson, R., "Photopheresis: A Clinically Relevant Immunobiologic Response Modifier," Annals of N.Y. Academy of Sciences 636:154-164 (1991).
Gasparro, F., et al., "Cell membrane DNA: a new target for psoralen photoadduct formation," Photochem. Photobiol. 52:315-321 (1990).
Cimino, G. D., et al., "Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry," Ann. Rev. Biochem. 54:1151-1193 (1985).
Kanne, D., et al., "Psoralen-deoxyribonucleic acid photoreaction Characterization of the monoaddition products from 8-methoxypsoralen and 4,5', 8-trimethylpsoralen," Biochemistry 21:861-871 (1982).
Edelson, R., "Light-activated Drugs," Scientific American 256(8): 68-75 (1988).
Tessman, J. W., et al., "Photochemistry of the furan-side 8-methoxypsoralen-thyamine monoadduct inside the DNA helix. Conversion to diadduct and to pyrone-side monoadduct," Biochemistry 24:1669-1676 (1985).
Spielmann, H., et al., "New Methods for the Large-Scale Synthesis of Furanside Psoralen Monoadducts and Diadducts," Photochem. Photobiol. 53:1135 (1991).
Sastry, S., et al., "Recent advances in the synthesis and structure determination of site specific psoralen-modified DNA oligonucleotides," J. Photochem. Photobiol. B: Biol. 14:65-79 (1992).
Averbeck, D., "Mutagenesis by psoralens on eukaryotic cells," Photosensitization, ed. G. Moreno NATO ASI Series 15:279-291 (1988).
Averbeck D., "Recent advances in psoralen phototoxicity mechanism," Photochem. Photobiol. 50:859-882 (1989).
Sage, E., and Bredberg, A., "Damage distribution and mutation spectrum: the case of 8-methoxypsoralen plus UVA in mammalian cells," Mutation Research 263:217-222 (1991).
Cundari, E., Averbeck, D., "8-Methoxypsoralen-photoinduced DNA crosslinks as determined in yeast by alkaline step elution under different reirradiation conditions. Relation with genetic effects," Photochem. Photobiol. 48:315-320 (1988).
Bredberg, A. and Nachmansson, N., "Psoralen adducts in a shuttle vector plasmid propagated in primate cells: High mutagenicity of DNA cross-links," Carcinogenesis 8:1923-1927 (1987).
Edelson, R., et al., "Treatment of cutaneous T Cell lymphoma by extracorporeal photochemotherapy," N. Engl. J. Med. 316:297-303 (1987).
Averbeck, D., et al., "Mutagenic and recombinogenic action of DNA monoadducts photoinduced by the bifunctional furocoumarin 8-Methoxypsoralen in yeast (Saccharomyces cerevisiae)," Photochem. Photobiol. 45:371-379 (1987).
Cassier, C., et al., "Mutagenic and recombinogenic effects of DNA cross-links induced in yeast by 8-methoxypsoralen photoaddition," Photochem. Photobiol. 39:799-803 (1984).
Singhal, R. P., et al., "High-performance liquid chromatography for trace analysis of DNA and kinetics of CNA modification," BioChrom. 4:78-88 (1989).
Malane, M. and Gasparro, R., "T Cell Molecular Targets for Psoralens," Annals of N.Y. Academy of Science 636:196-208 (1991).
Sage, E., and Moustacchi, E., "Sequence context effects on 8-methoxypsoralen photobinding to defined DNA fragments," Biochemistry 26:3307-3314 (1987).
Potapenko, A. Y., "Mechanisms of photodynamic effects of furocoumarins," J. Photochem. Photobiol. B 9:1-33 (1991).
Babudri, N., et al., "Mutation Induction and killing of V79 chinese hamster cells by 8-methoxypsoralen plus near-ultraviolet light: relative effects of monoadducts and crosslinks," Mutation Res. 91:391-394 (1981).
Yang, et al., "8-MOP DNA Photoadducts in Patients Treated with 8-MOP and UVA," J. Invest. Dermatol. 92:59-63 (1989).
Deckelbaum, L., et al., "Inhibition of Smooth Muscle Cell Proliferation by 8-Methoxypsoralen Photoactivated by Visible Light," American Heart Assoc. 65th Scientific Session, abstract No. 135231 (1992).
Gasparro, F. P., et al., "Repair of 8-MOP photoadducts in human lymphocytes," DNA Damage and Repair in Human Tissues (eds. B. M. Sutherland and A. D. Woodhead) Plenum Press, N.Y., P. 137 (1990).
Bevilacqua, P. M., et al., "High performance liquid Chromatography analysis of 8-methoxypsoralen monoadducts and crosslinks in lymphocytes and keratinocytes," J. Invest. Dermatol. 97:151-155 (1991).
Gasparro, F. P., et al., "Rapid and sensitive analysis of 8-methoxypsoralen in plasma," J. Invest. Dermatol. 90:234-236 (1988).
Hosken, N. A., et al., "Class I-Restricted Presentation Occurs Without Internalization or Processing of Exogenous Antigenic Peptides," The Journal of Immunology, vol. 142:1079-1083 (Feb. 15, 1989).
Townsend, A. R. M., et al., "The Epitopes of Influenza Nucleoprotein Recognized by Cytotoxic T Lymphocytes Can be Defined with Short Synthetic Peptides," Cell, vol. 44:959-968 (Mar. 28, 1986).
Deckelbaum, et al.; Circulation, vol. 86, No. 4 Suppl. 1, p. 1227 (Abstract); 1992.
Rook; Annals of the New York Academy of Sciences, vol. 636, pp. 209-216; 1991.
Malawista, et al.; Annals of the New York Academy of Sciences, vol. 636, pp. 217-226; 1991.
Berger, et al.; Annals of the New York Academy of Sciences, vol. 636, pp. 266-278; 1991.
Bisaccia, et al.; Annals of the New York Academy of Sciences, vol. 636, pp. 321-330; 1991.
Knoblier, et al.; Annals of the New York Academy of Sciences, vol. 636, pp. 340-356; 1991.
Ullrich; Photodermatology Photoimmunology Photomedicine, vol. 8, No. 3, pp. 116-122; 1991.
Alcalay, et al.; Photochemistry & Photobiology, vol. 50, No. 2, pp. 217-220; 1989.
Cundari, et al.; Mutation Research, vol. 264, pp. 97-102; 1991.
Edelson Richard L.
Gasparro Francis P.
Gambel Phillip
Lacey David L.
Yale University
LandOfFree
Immune system modulation using psoralens activated with visible does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immune system modulation using psoralens activated with visible , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune system modulation using psoralens activated with visible will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1770626